MDbox and Blink Science Partner to Bring Telehealth to blinkHEALTHPASS™

AUSTIN, Texas, August 27, 2021 (Newswire.com) - Reliant Immune Diagnostics has partnered with Blink Science, developer of the enterprise health and safety app blinkHEALTHPASS™, to bring its MDbox service to blinkHEALTHPASS™ users. 

As traditional healthcare facilities are once again overwhelmed with COVID-19 patients, the MDbox telemedicine service provides an alternative, allowing patients to video chat with a healthcare provider on their phone from the comfort of their home, 24 hours a day, seven days a week. Users pay a flat fee per visit and no appointment is required.

"As companies look to bring employees back to the office, frequent testing for COVID-19 is essential," expressed Henry Legere, MD, CEO and Founder of Reliant Immune Diagnostics. "Our partnership with Blink Science will provide those who test positive for Covid a quick and easy way to visit a medical professional without the cost and time commitment of an ER or urgent care."

blinkHEALTHPASS™ uses a mobile app and private, HIPAA-compliant cloud that helps companies aggregate and standardize third-party COVID test and vaccination data for employees, ensuring a safe operating environment while maintaining privacy.

"Our goal is to maximize the health of our client organizations," said Eric Doherty, President of Blink Science. "In addition to our comprehensive testing and data solutions, MDbox will enable us to provide access to quick, affordable care from the convenience of a smartphone."

About MDbox

The MDbox telemedicine app was developed by Reliant Immune Diagnostics to provide cost-effective quality symptom-specific consumer-driven healthcare and wellness to everyone. MDbox allows patients to visit with a licensed medical professional, receive prescriptions at the pharmacy of their choice, and understand the next steps required to treat their condition.

Learn more at www.mdbox.com

Media Contact: Emmanuel Colliot - [email protected]

About Blink Science

At Blink Science, we endeavor to maximize global health with high-tech, low-cost medical diagnostics and health information technologies. Our goal is to revolutionize point-of-care (POC) testing to ensure safe, fast, precise diagnosis and treatment for acute and chronic conditions that impact people throughout the world.

Learn more at blinkscience.com

Media Contact: Todd Bennett, [email protected]

Source: Reliant Immune Diagnostics